| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 3.42e-05 | 9 | 20 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 6.25e-05 | 12 | 20 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 7.78e-05 | 465 | 20 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.03e-04 | 301 | 20 | 4 | GO:0022853 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.38e-04 | 23 | 20 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.05e-04 | 26 | 20 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.15e-04 | 627 | 20 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 4.10e-04 | 664 | 20 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | symporter activity | 4.31e-04 | 150 | 20 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.40e-04 | 151 | 20 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 5.90e-04 | 167 | 20 | 3 | GO:0015079 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 7.50e-04 | 758 | 20 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 8.29e-04 | 775 | 20 | 5 | GO:0017111 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 9.19e-04 | 793 | 20 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.15e-03 | 477 | 20 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.18e-03 | 839 | 20 | 5 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.19e-03 | 840 | 20 | 5 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.19e-03 | 840 | 20 | 5 | GO:0016818 | |
| GeneOntologyMolecularFunction | channel activity | 1.64e-03 | 525 | 20 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.65e-03 | 526 | 20 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.05e-03 | 296 | 20 | 3 | GO:0015291 | |
| GeneOntologyMolecularFunction | GDP binding | 4.71e-03 | 103 | 20 | 2 | GO:0019003 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 5.26e-03 | 1180 | 20 | 5 | GO:0022857 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 5.74e-03 | 1205 | 20 | 5 | GO:0046983 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.24e-03 | 119 | 20 | 2 | GO:0015294 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 6.86e-03 | 125 | 20 | 2 | GO:0015108 | |
| GeneOntologyMolecularFunction | calcium channel activity | 7.29e-03 | 129 | 20 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | transporter activity | 7.63e-03 | 1289 | 20 | 5 | GO:0005215 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 7.91e-03 | 815 | 20 | 4 | GO:0042803 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 9.22e-03 | 441 | 20 | 3 | GO:0016887 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 9.87e-03 | 151 | 20 | 2 | GO:0008509 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.25e-02 | 171 | 20 | 2 | GO:0015103 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 2.23e-02 | 614 | 20 | 3 | GO:0140657 | |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 5.35e-06 | 4 | 20 | 2 | GO:0140157 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 6.92e-05 | 13 | 20 | 2 | GO:0072488 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 1.60e-04 | 112 | 20 | 3 | GO:0055038 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 1.68e-04 | 114 | 20 | 3 | GO:0005798 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle | 6.64e-04 | 40 | 20 | 2 | GO:0030140 | |
| GeneOntologyCellularComponent | recycling endosome | 1.18e-03 | 222 | 20 | 3 | GO:0055037 | |
| MousePheno | pigmentation phenotype | 1.08e-05 | 624 | 19 | 7 | MP:0001186 | |
| MousePheno | abnormal coat/hair pigmentation | 1.46e-05 | 424 | 19 | 6 | MP:0002075 | |
| Domain | KCC1 | 1.09e-06 | 2 | 20 | 2 | IPR000622 | |
| Domain | KCL_cotranspt | 6.53e-06 | 4 | 20 | 2 | IPR000076 | |
| Domain | SLC12A_fam | 2.28e-05 | 7 | 20 | 2 | IPR004842 | |
| Domain | SLC12_C | 3.04e-05 | 8 | 20 | 2 | IPR018491 | |
| Domain | SLC12 | 3.04e-05 | 8 | 20 | 2 | PF03522 | |
| Domain | AA-permease/SLC12A_dom | 2.48e-04 | 22 | 20 | 2 | IPR004841 | |
| Domain | AA_permease | 2.48e-04 | 22 | 20 | 2 | PF00324 | |
| Domain | RAB | 2.74e-03 | 73 | 20 | 2 | PS51419 | |
| Domain | - | 7.34e-03 | 746 | 20 | 4 | 3.40.50.300 | |
| Domain | Ras | 9.18e-03 | 136 | 20 | 2 | PF00071 | |
| Domain | P-loop_NTPase | 1.14e-02 | 848 | 20 | 4 | IPR027417 | |
| Domain | Small_GTPase | 1.25e-02 | 160 | 20 | 2 | IPR001806 | |
| Domain | Small_GTP-bd_dom | 1.36e-02 | 167 | 20 | 2 | IPR005225 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 3.22e-05 | 7 | 18 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 3.22e-05 | 7 | 18 | 2 | MM15081 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.28e-04 | 108 | 18 | 3 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.37e-04 | 109 | 18 | 3 | MM15074 | |
| Pathway | REACTOME_TBC_RABGAPS | 8.94e-04 | 35 | 18 | 2 | MM15494 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.31e-03 | 681 | 18 | 5 | MM14985 | |
| Pathway | REACTOME_TBC_RABGAPS | 1.41e-03 | 44 | 18 | 2 | M27748 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.86e-03 | 736 | 18 | 5 | M27287 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 17510708 | ||
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 3.14e-07 | 2 | 20 | 2 | 34031912 | |
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 3.14e-07 | 2 | 20 | 2 | 31835175 | |
| Pubmed | 4.92e-07 | 113 | 20 | 4 | 30352685 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 31352162 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 31707148 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 12221131 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 11551954 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 15262997 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 28076793 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 35274823 | ||
| Pubmed | K-Cl cotransporter gene expression during human and murine erythroid differentiation. | 9.42e-07 | 3 | 20 | 2 | 21733850 | |
| Pubmed | Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. | 1.88e-06 | 4 | 20 | 2 | 26471730 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 12637262 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 24213529 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 18094055 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 5.67e-06 | 468 | 20 | 5 | 31056421 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 7.73e-06 | 499 | 20 | 5 | 22810586 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 8.78e-06 | 8 | 20 | 2 | 21613606 | |
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 11395011 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 8.78e-06 | 8 | 20 | 2 | 24393035 | |
| Pubmed | 8.78e-06 | 8 | 20 | 2 | 12386165 | ||
| Pubmed | GRAF2, WDR44, and MICAL1 mediate Rab8/10/11-dependent export of E-cadherin, MMP14, and CFTR ΔF508. | 1.13e-05 | 9 | 20 | 2 | 32344433 | |
| Pubmed | 1.13e-05 | 9 | 20 | 2 | 19323993 | ||
| Pubmed | 2.07e-05 | 12 | 20 | 2 | 27782176 | ||
| Pubmed | Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. | 2.07e-05 | 12 | 20 | 2 | 18329369 | |
| Pubmed | 2.44e-05 | 13 | 20 | 2 | 26833786 | ||
| Pubmed | Phosphodiesterase 2A2 regulates mitochondria clearance through Parkin-dependent mitophagy. | 3.02e-05 | 106 | 20 | 3 | 33087821 | |
| Pubmed | 4.25e-05 | 17 | 20 | 2 | 37042948 | ||
| Pubmed | 4.78e-05 | 18 | 20 | 2 | 21255211 | ||
| Pubmed | 4.78e-05 | 18 | 20 | 2 | 12639940 | ||
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 7.21e-05 | 22 | 20 | 2 | 18391953 | |
| Pubmed | Afadin and RhoA control pancreatic endocrine mass via lumen morphogenesis. | 7.89e-05 | 23 | 20 | 2 | 29330353 | |
| Pubmed | 1.02e-04 | 438 | 20 | 4 | 32628020 | ||
| Pubmed | 1.67e-04 | 952 | 20 | 5 | 38569033 | ||
| Pubmed | 1.76e-04 | 504 | 20 | 4 | 34432599 | ||
| Pubmed | Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. | 2.07e-04 | 37 | 20 | 2 | 20937701 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 2.77e-04 | 1061 | 20 | 5 | 33845483 | |
| Pubmed | 2.77e-04 | 568 | 20 | 4 | 37774976 | ||
| Pubmed | Functional dissection of Rab GTPases involved in primary cilium formation. | 2.80e-04 | 43 | 20 | 2 | 17646400 | |
| Pubmed | 3.27e-04 | 237 | 20 | 3 | 29564676 | ||
| Pubmed | 3.35e-04 | 239 | 20 | 3 | 23246001 | ||
| Pubmed | Protein Binder Toolbox for Studies of Solute Carrier Transporters. | 4.75e-04 | 56 | 20 | 2 | 38878854 | |
| Pubmed | 4.75e-04 | 56 | 20 | 2 | 27103069 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 4.93e-04 | 1203 | 20 | 5 | 29180619 | |
| Pubmed | 5.09e-04 | 58 | 20 | 2 | 11856727 | ||
| Pubmed | 5.63e-04 | 61 | 20 | 2 | 12578829 | ||
| Interaction | RHOH interactions | 5.35e-06 | 512 | 19 | 6 | int:RHOH | |
| Interaction | RHOB interactions | 6.92e-06 | 840 | 19 | 7 | int:RHOB | |
| Interaction | ARF6 interactions | 1.13e-05 | 584 | 19 | 6 | int:ARF6 | |
| Interaction | RAB5C interactions | 1.32e-05 | 600 | 19 | 6 | int:RAB5C | |
| Interaction | TMEM41B interactions | 1.42e-05 | 162 | 19 | 4 | int:TMEM41B | |
| Interaction | OR10S1 interactions | 2.35e-05 | 8 | 19 | 2 | int:OR10S1 | |
| Interaction | TACR1 interactions | 3.58e-05 | 69 | 19 | 3 | int:TACR1 | |
| Interaction | RAB7A interactions | 1.18e-04 | 886 | 19 | 6 | int:RAB7A | |
| Interaction | OR2G6 interactions | 1.28e-04 | 18 | 19 | 2 | int:OR2G6 | |
| Interaction | RHOG interactions | 1.36e-04 | 910 | 19 | 6 | int:RHOG | |
| Interaction | SLC24A3 interactions | 1.58e-04 | 20 | 19 | 2 | int:SLC24A3 | |
| Interaction | PDE2A interactions | 1.86e-04 | 120 | 19 | 3 | int:PDE2A | |
| Interaction | KCNE1 interactions | 1.92e-04 | 22 | 19 | 2 | int:KCNE1 | |
| Interaction | ZDHHC12 interactions | 2.00e-04 | 123 | 19 | 3 | int:ZDHHC12 | |
| Interaction | SYVN1 interactions | 2.10e-04 | 324 | 19 | 4 | int:SYVN1 | |
| Interaction | RHOF interactions | 3.22e-04 | 673 | 19 | 5 | int:RHOF | |
| Interaction | RAC2 interactions | 3.24e-04 | 674 | 19 | 5 | int:RAC2 | |
| Interaction | ELOVL5 interactions | 3.27e-04 | 364 | 19 | 4 | int:ELOVL5 | |
| Interaction | TMC4 interactions | 3.61e-04 | 30 | 19 | 2 | int:TMC4 | |
| Interaction | LYPD6 interactions | 4.37e-04 | 33 | 19 | 2 | int:LYPD6 | |
| Interaction | PIGH interactions | 4.41e-04 | 161 | 19 | 3 | int:PIGH | |
| Interaction | LGALS9C interactions | 4.92e-04 | 35 | 19 | 2 | int:LGALS9C | |
| Interaction | RHOA interactions | 6.07e-04 | 1199 | 19 | 6 | int:RHOA | |
| Interaction | MS4A15 interactions | 6.11e-04 | 39 | 19 | 2 | int:MS4A15 | |
| Interaction | RPH3A interactions | 6.11e-04 | 39 | 19 | 2 | int:RPH3A | |
| Interaction | HSD17B10 interactions | 6.36e-04 | 434 | 19 | 4 | int:HSD17B10 | |
| Interaction | NRN1 interactions | 6.43e-04 | 40 | 19 | 2 | int:NRN1 | |
| Interaction | ZFC3H1 interactions | 6.62e-04 | 185 | 19 | 3 | int:ZFC3H1 | |
| Interaction | RND2 interactions | 6.70e-04 | 440 | 19 | 4 | int:RND2 | |
| Interaction | LGALS9B interactions | 8.14e-04 | 45 | 19 | 2 | int:LGALS9B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 2.86e-03 | 183 | 20 | 2 | chr16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 3.37e-03 | 199 | 20 | 2 | chr9q21 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 1.67e-03 | 65 | 17 | 2 | 388 | |
| GeneFamily | Solute carriers | 5.60e-03 | 395 | 17 | 3 | 752 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN | 1.45e-05 | 200 | 20 | 4 | M4066 | |
| Coexpression | GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN | 1.45e-05 | 200 | 20 | 4 | M9773 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 5.09e-05 | 1399 | 20 | 7 | M535 | |
| Coexpression | VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP | 5.77e-05 | 15 | 20 | 2 | M1540 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP | 3.96e-04 | 191 | 20 | 3 | M8671 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP | 3.96e-04 | 191 | 20 | 3 | M8681 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN | 4.34e-04 | 197 | 20 | 3 | M5853 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN | 4.34e-04 | 197 | 20 | 3 | M5877 | |
| Coexpression | GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN | 4.40e-04 | 198 | 20 | 3 | M5861 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP | 4.47e-04 | 199 | 20 | 3 | M3846 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN | 4.47e-04 | 199 | 20 | 3 | M5240 | |
| Coexpression | GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN | 4.53e-04 | 200 | 20 | 3 | M7286 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 4.53e-04 | 200 | 20 | 3 | M5851 | |
| Coexpression | GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN | 4.53e-04 | 200 | 20 | 3 | M5859 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN | 4.53e-04 | 200 | 20 | 3 | M5870 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP | 4.53e-04 | 200 | 20 | 3 | M4570 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP | 4.53e-04 | 200 | 20 | 3 | M8850 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 4.53e-04 | 200 | 20 | 3 | M6092 | |
| Coexpression | GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN | 4.53e-04 | 200 | 20 | 3 | M8694 | |
| Coexpression | PARK_HSC_MARKERS | 5.13e-04 | 44 | 20 | 2 | M6509 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 122 | 20 | 3 | 032b5da8befcb1a159245f8d0c67f91795883ee0 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.55e-05 | 157 | 20 | 3 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 5.37e-05 | 166 | 20 | 3 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-05 | 171 | 20 | 3 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-05 | 171 | 20 | 3 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.86e-05 | 171 | 20 | 3 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 5.86e-05 | 171 | 20 | 3 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.97e-05 | 172 | 20 | 3 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.97e-05 | 172 | 20 | 3 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.97e-05 | 172 | 20 | 3 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.50e-05 | 177 | 20 | 3 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 184 | 20 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-05 | 184 | 20 | 3 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 184 | 20 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 184 | 20 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 185 | 20 | 3 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 185 | 20 | 3 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | ASK452-Immune-Mast_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.77e-05 | 188 | 20 | 3 | 840215e16cff90f821f776186284eafcf2350690 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 188 | 20 | 3 | 90188b60ff893754f7938fe8edab79758827168e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 8.92e-05 | 197 | 20 | 3 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Others-HSPC|COVID-19_Convalescent / Disease, condition lineage and cell class | 8.92e-05 | 197 | 20 | 3 | c1033a1a8b8b5c8569130aa9405a6e8e65ef7bd0 | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 9.06e-05 | 198 | 20 | 3 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 9.33e-05 | 200 | 20 | 3 | 3813fa1ee1462ba83fd8b6253070f46f0b063084 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 9.33e-05 | 200 | 20 | 3 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Neuronal-Cortical_neuron|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 8.01e-04 | 94 | 20 | 2 | a752c80fb2e83cffa22a00d7e98c24406ee41908 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-03 | 117 | 20 | 2 | f0c738b6b850733f9af68704172554177a1c1198 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-03 | 117 | 20 | 2 | b5cb9d69ddd42331134f7e4bd51bd1c31030893c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Nptx2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-03 | 122 | 20 | 2 | 91e338db581b36baffecc323b1909f2069b27242 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-03 | 128 | 20 | 2 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-03 | 131 | 20 | 2 | d706405453408fbcfcabb1c7702b80f9e649ffca | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l14|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-03 | 132 | 20 | 2 | 14a512f433315892bf0326419f23d0d5919d01ec | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-03 | 133 | 20 | 2 | 81189e8516a431d5890a0909f9fc7c82ec3442bc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.66e-03 | 136 | 20 | 2 | 9cf076597e6fd9390850fda259daa13022f15893 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-03 | 136 | 20 | 2 | 82d7f90ef2a63a3137c331efd68c036cd0db3ac1 | |
| ToppCell | Control-Mast_cells-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.69e-03 | 137 | 20 | 2 | 9906225a2eb1a891e5bfbb00929bc041f325b376 | |
| ToppCell | COVID-19-Mast_cells-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.79e-03 | 141 | 20 | 2 | 0fc06c2325249aa4ae65c0ace1ec3f953372f2e4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-03 | 142 | 20 | 2 | 58c2882cb0ede8cc5d84c85a650d28267268e748 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.86e-03 | 144 | 20 | 2 | 76c0e551864c4faab7528c4ecf1a40d7ea60569f | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-03 | 144 | 20 | 2 | 013223bb2f31eb5bebdbd0908b797d28b96c6f7b | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 1.89e-03 | 145 | 20 | 2 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 1.89e-03 | 145 | 20 | 2 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | COVID-19-Mast_cells-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 1.89e-03 | 145 | 20 | 2 | 5c5fed4620c4c312d1052b8acad910453f7e8fcc | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-03 | 146 | 20 | 2 | f7349d63bb47f1f22ced8ff514edc1c11bc782e7 | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-03 | 148 | 20 | 2 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-03 | 148 | 20 | 2 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | MS-CD4-CD8_2|MS / Condition, Cell_class and T cell subcluster | 1.99e-03 | 149 | 20 | 2 | 08fb6be5599c5988890c851ce5ac6781c319948e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-03 | 150 | 20 | 2 | 1270f33f9d7e46e55adf1a96e8beee858b95589d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-03 | 150 | 20 | 2 | 156118ce1d69522624196410cba18b8354cd0bb4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-03 | 151 | 20 | 2 | f5ae450e3daa10540ca8437d05efe2d86ac70960 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.04e-03 | 151 | 20 | 2 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-03 | 152 | 20 | 2 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Mast_cell-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-03 | 152 | 20 | 2 | 321d322d58c12fd752de4e8ea873f3f367302813 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-03 | 152 | 20 | 2 | a4d50e9af02231c5573aee905cf0905391e6da34 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.07e-03 | 152 | 20 | 2 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.07e-03 | 152 | 20 | 2 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.07e-03 | 152 | 20 | 2 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-03 | 153 | 20 | 2 | 83942ef63d21725fa15ed5a91481d1f9936e8f11 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.10e-03 | 153 | 20 | 2 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|World / disease group, cell group and cell class (v2) | 2.10e-03 | 153 | 20 | 2 | 2b4c69f6db17927d6506a645ac058133e60b0103 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-03 | 153 | 20 | 2 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | mild_COVID-19_(asymptomatic)-MAIT|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.10e-03 | 153 | 20 | 2 | 26852f3d8f80e102e24bcb90e24aac26fdc9a32c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-03 | 155 | 20 | 2 | 231fbbbd6e6f9c86be7a15a9ec0804e6b9ab3b5f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.15e-03 | 155 | 20 | 2 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-03 | 155 | 20 | 2 | 96c48d835725eac1bc7926f4cddecb67c29b7d7c | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.15e-03 | 155 | 20 | 2 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | Control-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 2.15e-03 | 155 | 20 | 2 | 4b9369b203a4d7071c56d3d8e6b450e9a0121c41 | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.18e-03 | 156 | 20 | 2 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-03 | 156 | 20 | 2 | a4b0e89255ea5d60198cb2b3e739981f9c9cf5c5 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.18e-03 | 156 | 20 | 2 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.18e-03 | 156 | 20 | 2 | 17c38d3b03fc38cb125cf0d165b2fd694cd88edd | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-03 | 157 | 20 | 2 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-03 | 157 | 20 | 2 | ed9c9feefc06c9536c03bedbc3397a2ee492a78e | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.21e-03 | 157 | 20 | 2 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-03 | 157 | 20 | 2 | fddcb24776b9f86e000208bae54541b15b2adefd | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK_CD56bright|Leuk-UTI / Disease, Lineage and Cell Type | 2.21e-03 | 157 | 20 | 2 | db0057741d06e212a9543cb4b011659b79efeafc | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.21e-03 | 157 | 20 | 2 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-03 | 158 | 20 | 2 | 91d8c93af328c3bbebe1d8f019b94849ebc548c0 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.23e-03 | 158 | 20 | 2 | 0c27c475289c70b17b6a66fc71f628511c5f0ae1 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.26e-03 | 159 | 20 | 2 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.26e-03 | 159 | 20 | 2 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | 10x5'-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 2.26e-03 | 159 | 20 | 2 | c3d3570e83c5d25cc92fa3a7a8f0dc2f89a72913 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-03 | 159 | 20 | 2 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.26e-03 | 159 | 20 | 2 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.29e-03 | 160 | 20 | 2 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-03 | 160 | 20 | 2 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.29e-03 | 160 | 20 | 2 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-03 | 160 | 20 | 2 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-03 | 161 | 20 | 2 | deb10628d258fb813c293f81fb71be8e383dc82a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-03 | 161 | 20 | 2 | 8aaca49b53a551395f4025ac4e535c7b0ce41a49 | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 2.32e-03 | 161 | 20 | 2 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 2.32e-03 | 161 | 20 | 2 | 15ba7e69699558353cfeecdcf1dbc2e147379ed6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-03 | 161 | 20 | 2 | 20ac00dcdab2926b6e68862e1714fc68a032844b | |
| ToppCell | Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, Lineage and Cell Type | 2.32e-03 | 161 | 20 | 2 | bcd122af09cbb99d1816200d9c367af8b7f36873 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-03 | 161 | 20 | 2 | c54010d88f1ecb6e0235bb66084876a4d5bf1ecd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-03 | 163 | 20 | 2 | 39181c58387189a815e7b3eb29fbd1dd4ee24d0a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.37e-03 | 163 | 20 | 2 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-03 | 163 | 20 | 2 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-03 | 164 | 20 | 2 | 35c673380f75cb4bfe080089bc723c4373bcc7a5 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-03 | 164 | 20 | 2 | 12251a49fd4af32d4edb58046245548c260cf04b | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 2.40e-03 | 164 | 20 | 2 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| Drug | Potassium Chloride | 1.10e-05 | 6 | 20 | 2 | DB00761 | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.46e-05 | 199 | 20 | 4 | 5436_UP | |
| Drug | Fosfosal [6064-83-1]; Up 200; 18.4uM; HL60; HT_HG-U133A | 2.51e-05 | 200 | 20 | 4 | 2997_UP | |
| Drug | AC1L1ICP | 3.28e-05 | 10 | 20 | 2 | CID000004520 | |
| Drug | Rubidium chromate | 3.61e-05 | 74 | 20 | 3 | CID000061605 | |
| Drug | DCPIB | 4.01e-05 | 11 | 20 | 2 | CID010071166 | |
| Drug | Bumetanide | 8.73e-05 | 16 | 20 | 2 | ctd:D002034 | |
| Disease | Dyggve-Melchior-Clausen disease (implicated_via_orthology) | 2.36e-06 | 4 | 19 | 2 | DOID:0111167 (implicated_via_orthology) | |
| Disease | Smith-McCort dysplasia (implicated_via_orthology) | 3.92e-06 | 5 | 19 | 2 | DOID:0060247 (implicated_via_orthology) | |
| Disease | Cleft palate, cleft lip | 2.71e-05 | 279 | 19 | 4 | EFO_0003959, HP_0000175 | |
| Disease | epilepsy (implicated_via_orthology) | 1.50e-04 | 163 | 19 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | major depressive episode | 4.17e-04 | 47 | 19 | 2 | EFO_0007634 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 8.18e-04 | 291 | 19 | 3 | EFO_0008317, EFO_0020946 | |
| Disease | mean platelet volume | 3.63e-03 | 1020 | 19 | 4 | EFO_0004584 | |
| Disease | unipolar depression, bipolar disorder | 4.48e-03 | 156 | 19 | 2 | EFO_0003761, MONDO_0004985 | |
| Disease | pancreatic carcinoma | 5.53e-03 | 174 | 19 | 2 | EFO_0002618 | |
| Disease | bipolar disorder | 5.71e-03 | 577 | 19 | 3 | MONDO_0004985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSMMKYYYECVLFVV | 391 | Q8N4J0 | |
| YMALYSMIQYVGVLL | 906 | Q4VNC1 | |
| AYYRGAMGIMLVYDI | 76 | P61006 | |
| AYYRGAMGIMLVYDI | 76 | Q92930 | |
| EKHRMYMGQRYVEVY | 211 | Q12849 | |
| MMYAQEKGIYYIQLE | 246 | Q9UM21 | |
| MILTYKYLQKPMYEV | 541 | P10721 | |
| MVEDYYKGIRQMVQV | 1751 | O15031 | |
| LVVGMYYGAALFMYI | 246 | Q8NG83 | |
| MYMLIWGKFVLYKYV | 271 | Q6P1A2 | |
| LMYLIYIVIMKYNAC | 246 | Q9HC58 | |
| MVYYQGVLDQMNKYL | 26 | O75449 | |
| YYAIVAMVIAGMIYK | 701 | Q9UHW9 | |
| AMVIAGMIYKYIEYQ | 706 | Q9UHW9 | |
| YVYQPMEKLYMVLIT | 56 | P48444 | |
| LYYQTNYLVVAAMMI | 41 | O75915 | |
| YYALVAMLIAGMIYK | 636 | Q9UP95 | |
| AMLIAGMIYKYIEYQ | 641 | Q9UP95 | |
| IGYLMLFNYIVLVKM | 906 | Q9HCF6 | |
| MIKQILYTAYGEIYM | 2376 | Q6N022 | |
| YIVYHELVMTTKEYM | 1116 | Q92620 | |
| KIYYVYGFMMLVLVI | 476 | Q9HD45 |